Gilead Calistoga LLC

États‑Unis d’Amérique

 
Quantité totale PI 35
Rang # Quantité totale PI 41 045
Note d'activité PI 0,4/5.0    1
Rang # Activité PI 948 090

Brevets

Marques

16 0
4 0
15 0
0
 
Dernier brevet 2020 - Therapies for hematologic malign...
Premier brevet 2009 - Therapies for hematologic malign...

Derniers inventions, produits et services

2020 Invention Therapies for hematologic malignancies. The invention provides methods that relate to a novel th...
2017 Invention Process methods for phosphatidylinositol 3-kinase inhibitors. A process for the synthesis of quin...
Invention Polymorphic forms of a hydrochloride salt of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phen...
2016 Invention Process for preparing phosphatidylinositol 3-kinase inhibitors and intermediates thereof. A proce...
Invention Therapies for hematologic malignancies. The invention provides methods that relate to a novel the...
Invention Polymorphic forms of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3h)-one. ...
Invention Combination therapies for hematologic malignancies. The invention provides methods that relate t...
2015 Invention Phosphatidylinositol 3-kinase inhibitors. The present disclosure provides phosphatidylinositol 3...
Invention Phosphatidylinositol 3-kinase inhibitors. The present disclosure provides phosphatidylinositol 3-...
2014 Invention Process methods for phosphatidylinositol 3-kinase inhibitors. A process for the synthesis o...
Invention Polymorphic forms of a hydrochloride salt of (s) -2-(9h-purin-6-ylamino) propyl) -5-fluoro-3-phen...
2013 Invention Substituted pyrimidine aminoalkyl-quinazolones as phosphatidylinositol 3-kinase inhibitors. The p...
Invention Isoquinolinone or quinazolinone phosphatidylinositol 3-kinase inhibitors. The present disclosure ...
Invention Methods of treatment for solid tumors. The invention provides methods that relate to a novel the...
Invention Combination therapies for treating cancer. Provided herein are methods that relate to a novel the...
Invention Therapies for treating cancer. Provided herein are methods that relate to a novel therapeutic st...
Invention H)-one. Polymorphs of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one,...
Invention Compositions and methods of treating a disease with (s)-4 amino-6-((1-(5-chloro-4-oxo-3-phenyl-3,...
2012 Invention Compositions and methods of treating a proliferative disease with a quinazolinone derivative. Pr...
Invention Compositions and methods of treating a proliferative disease with a quinazolinone derivative. Pro...
Invention Novel quinoxaline inhibitors of pi3k. The invention provides methods that relate to a novel ther...
Invention Novel quinoxaline inhibitors of pi3k. The invention provides methods that relate to a novel thera...
Invention Combination therapies for hematologic malignancies. The invention provides methods that relate to...
2011 Invention Atropisomers of p13k-inhibiting compounds. The invention provides compounds, compositions and me...
Invention Atropisomers of pi3k-inhibiting compounds. The invention provides compounds, compositions and met...
Invention Methods of treating hematological disorders with quinazolinone compounds in selected patients. Th...
2010 Invention Treatment of liver disorders with pi3k inhibitors. The invention provides methods to treat certai...
Invention Methods of treatment for solid tumors. The invention provides methods that relate to a novel ther...